Madrigal Pharmaceuticals annual revenue
2009
2010
2011
2012
2017
2018
2019
2020
2021
2022
2023
2024
2025
Madrigal Pharmaceuticals Revenue Growth & History (MDGL)
Madrigal Pharmaceuticals reported $958.4M in revenue for fiscal 2025, an increase of 432.05% from the previous fiscal year.
View full Madrigal Pharmaceuticals company overviewMadrigal Pharmaceuticals annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $958.4M | $778.3M | +432.05% |
| 2024 | 2024-12-31 | $180.1M | $180.1M | — |
| 2023 | 2023-12-31 | $0 | $0 | — |
| 2022 | 2022-12-31 | $0 | $0 | — |
| 2021 | 2021-12-31 | $0 | $0 | — |
| 2020 | 2020-12-31 | $0 | $0 | — |
| 2019 | 2019-12-31 | $0 | $0 | — |
| 2018 | 2018-12-31 | $0 | $0 | — |
| 2017 | 2017-12-31 | $0 | — | — |
| 2012 | 2012-12-31 | $147,000 | −$7.4M | −98.06% |
| 2011 | 2011-12-31 | $7.6M | −$7.2M | −48.77% |
| 2010 | 2010-12-31 | $14.8M | −$129.4M | −89.74% |
| 2009 | 2009-12-31 | $144.2M | — | — |
Madrigal Pharmaceuticals quarterly revenue
Q2.10
Q3.10
Q1.11
Q2.11
Q3.11
Q4.11
Q1.12
Q2.12
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $364.3M | $151.4M | +71.17% |
| Q1 2026 | 2026-03-31 | $311.3M | $174.1M | +126.84% |
| Q4 2025 | 2025-12-31 | $321.1M | $217.8M | +210.77% |
| Q3 2025 | 2025-09-30 | $287.3M | $225.1M | +362.03% |
| Q2 2025 | 2025-06-30 | $212.8M | $198.2M | +1353.76% |
| Q1 2025 | 2025-03-31 | $137.3M | $137.3M | — |
| Q4 2024 | 2024-12-31 | $103.3M | $103.3M | — |
| Q3 2024 | 2024-09-30 | $62.2M | $62.2M | — |
| Q2 2024 | 2024-06-30 | $14.6M | $14.6M | — |
| Q1 2024 | 2024-03-31 | $0 | $0 | — |
| Q4 2023 | 2023-12-31 | $0 | $0 | — |
| Q3 2023 | 2023-09-30 | $0 | $0 | — |
| Q2 2023 | 2023-06-30 | $0 | $0 | — |
| Q1 2023 | 2023-03-31 | $0 | $0 | — |
| Q4 2022 | 2022-12-31 | $0 | $0 | — |
| Q3 2022 | 2022-09-30 | $0 | $0 | — |
| Q2 2022 | 2022-06-30 | $0 | $0 | — |
| Q1 2022 | 2022-03-31 | $0 | $0 | — |
| Q4 2021 | 2021-12-31 | $0 | $0 | — |
| Q3 2021 | 2021-09-30 | $0 | $0 | — |
| Q2 2021 | 2021-06-30 | $0 | $0 | — |
| Q1 2021 | 2021-03-31 | $0 | $0 | — |
| Q4 2020 | 2020-12-31 | $0 | $0 | — |
| Q3 2020 | 2020-09-30 | $0 | $0 | — |
| Q2 2020 | 2020-06-30 | $0 | $0 | — |
| Q1 2020 | 2020-03-31 | $0 | $0 | — |
| Q4 2019 | 2019-12-31 | $0 | $0 | — |
| Q3 2019 | 2019-09-30 | $0 | $0 | — |
| Q2 2019 | 2019-06-30 | $0 | $0 | — |
| Q1 2019 | 2019-03-31 | $0 | $0 | — |
| Q4 2018 | 2018-12-31 | $0 | — | — |
| Q3 2018 | 2018-09-30 | $0 | — | — |
| Q2 2018 | 2018-06-30 | $0 | — | — |
| Q1 2018 | 2018-03-31 | $0 | — | — |
| Q2 2012 | 2012-06-30 | $0 | −$1.4M | −100.00% |
| Q1 2012 | 2012-03-31 | $147,000 | −$996,000 | −87.14% |
| Q4 2011 | 2011-12-31 | $3.4M | — | — |
| Q3 2011 | 2011-09-30 | $1.7M | −$1.7M | −50.81% |
| Q2 2011 | 2011-06-30 | $1.4M | −$2.0M | −59.70% |
| Q1 2011 | 2011-03-31 | $1.1M | — | — |
| Q3 2010 | 2010-09-30 | $3.4M | — | — |
| Q2 2010 | 2010-06-30 | $3.4M | — | — |
Madrigal Pharmaceuticals revenue growth trends
Madrigal Pharmaceuticals's latest reported quarter, Q2 2026, generated $364.3M in revenue, an increase of 71.17% year over year.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review Madrigal Pharmaceuticals source filings ↗